Sun T, Campbell M, Gordon W, Arlinghaus R B
Department of Molecular Pathology, Box 89, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Biopolymers. 2001;60(1):61-75. doi: 10.1002/1097-0282(2001)60:1<61::AID-BIP1004>3.0.CO;2-4.
In this review, we describe methods to generate and characterize sequence-specific phosphoamino acid antibodies. Several of the early contributions regarding the utility of such antibodies are summarized. Three antiphosphopeptide antibodies derived from sequences of the Bcr protein are described. They are anti-Bcr pSer-354, anti-Bcr pTyr-328, and anti-Bcr pTyr-360. These anti-Bcr phosphopeptide antibodies are directed toward phosphorylated sequences encoded by the first exon of the BCR gene, which is the critical portion of the Bcr sequence present in the Bcr-Abl oncoprotein. Using these antibodies, we established/confirmed the in vivo phosphorylation of Ser-354, Tyr-328, and Tyr-360 in Bcr and Bcr-Abl proteins. The cross-reactivity of these antibodies, which is a common problem with antipeptide antibodies, was also investigated and discussed.
在本综述中,我们描述了生成和表征序列特异性磷酸氨基酸抗体的方法。总结了关于此类抗体效用的一些早期贡献。描述了三种源自Bcr蛋白序列的抗磷酸肽抗体。它们分别是抗Bcr pSer-354、抗Bcr pTyr-328和抗Bcr pTyr-360。这些抗Bcr磷酸肽抗体针对BCR基因第一个外显子编码的磷酸化序列,该序列是Bcr-Abl癌蛋白中Bcr序列的关键部分。使用这些抗体,我们确定/证实了Bcr和Bcr-Abl蛋白中Ser-354、Tyr-328和Tyr-360的体内磷酸化。还研究和讨论了这些抗体的交叉反应性,这是抗肽抗体常见的问题。